BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/13/2017 1:00:44 AM | Browse: 438 | Download: 531
Publication Name World Journal of Radiology
Manuscript ID 32990
Country/Territory Turkey
Received
2017-02-03 15:32
Peer-Review Started
2017-02-09 14:25
To Make the First Decision
2017-05-23 00:50
Return for Revision
2017-06-12 01:41
Revised
2017-06-24 16:08
Second Decision
2017-07-28 05:05
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-08-02 20:36
Articles in Press
2017-08-02 20:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-09-20 02:57
Publish the Manuscript Online
2017-10-13 01:00
ISSN 1949-8470 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report
Manuscript Source Invited Manuscript
All Author List Gulgun Engin, Serpil Eraslan, Hülya Kayserili, Yersu Kapran, Haluk Akman, Ali Akyuz and Nuri Faruk Aykan
Funding Agency and Grant Number
Corresponding Author Gulgun Engin, MD, Oncology Institute, Istanbul University, Millet Street, Capa 34390, Istanbul, Turkey. gengin@istanbul.edu.tr
Key Words Gastrointestinal stromal tumor; Familial; Germline mutation; Imatinib; Response
Core Tip Familial gastrointestinal stromal tumor (GIST) with exon 13 germline mutations are extremely rare. Moreover, there are only a few reports describing the response to imatinib in familial GISTs. The data on the role of imatinib in familial GISTs is still limited. Understanding the role of imatinib is important for the appropriate management of mutation positive familial GISTs. It is also crucial to be able to determine the role of specific germline KIT mutations in. We hereby report our findings in consideration of up-to-date information.
Publish Date 2017-10-13 01:00
Citation Engin G, Eraslan S, Kayserili H, Kapran Y, Akman H, Akyuz A, Aykan NF. Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report. World J Radiol 2017; In press
Url http://www.wjgnet.com/1949-8470/full/v9/i9/365.htm
DOI http://dx.doi.org/10.4329/wjr.v9.i9.365
Full Article (PDF) WJR-9-365.pdf
Full Article (Word) WJR-9-365.doc
Manuscript File 32990-Review.docx
Answering Reviewers 32990-Answering reviewers.pdf
Audio Core Tip 32990-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 32990-Conflict-of-interest statement.docx
Copyright License Agreement 32990-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s) 32990-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 32990-Institutional review board statement.pdf
Peer-review Report 32990-Peer-review(s).pdf
Scientific Misconduct Check 32990-Scientific misconduct check.pdf
Scientific Editor Work List 32990-Scientific editor work list.pdf